Browse > Article
http://dx.doi.org/10.5483/BMBRep.2017.50.3.189

Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells  

Oh, Sunhwa (Department of Life Science, Hanyang University)
Kim, Hyungjoo (Department of Life Science, Hanyang University)
Nam, KeeSoo (Department of Life Science, Hanyang University)
Shin, Incheol (Department of Life Science, Hanyang University)
Publication Information
BMB Reports / v.50, no.3, 2017 , pp. 132-137 More about this Journal
Abstract
Elevated glucose levels in cancer cells can be attributed to increased levels of glucose transporter (GLUT) proteins. Glut1 expression is increased in human malignant cells. To investigate alternative roles of Glut1 in breast cancer, we silenced Glut1 in triple-negative breast-cancer cell lines using a short hairpin RNA (shRNA) system. Glut1 silencing was verified by Western blotting and qRT-PCR. Knockdown of Glut1 resulted in decreased cell proliferation, glucose uptake, migration, and invasion through modulation of the EGFR/MAPK signaling pathway and integrin ${\beta}1$/Src/FAK signaling pathways. These results suggest that Glut1 not only plays a role as a glucose transporter, but also acts as a regulator of signaling cascades in the tumorigenesis of breast cancer.
Keywords
Breast cancer cell; EGFR; Glut; Integrin ${\beta}1$; Triple-negative breast cancer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Warburg O (1956) On the origin of cancer cells. Science 123, 309-314   DOI
2 Cairns RA, Harris IS and Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11, 85-95   DOI
3 Kunkel M, Reichert TE, Benz P et al (2003) Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97, 1015-1024   DOI
4 Kang SS, Chun YK, Hur MH et al (2002) Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res 93, 1123-1128   DOI
5 Brenton JD, Carey LA, Ahmed AA and Caldas C (2005) Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23, 7350-7360   DOI
6 Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406, 747-752   DOI
7 Badve S, Dabbs DJ, Schnitt SJ et al (2011) Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol 24, 157-167   DOI
8 Hussein YR, Bandyopadhyay S, Semaan A et al (2011) Glut-1 Expression Correlates with Basal-like Breast Cancer. Transl Oncol 4, 321-327   DOI
9 Nielsen TO, Hsu FD, Jensen K et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10, 5367-5374   DOI
10 Wood IS and Trayhurn P (2003) Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 89, 3-9
11 Olayioye MA, Neve RM, Lane HA and Hynes NE (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19, 3159-3167   DOI
12 Dhillon AS, Hagan S, Rath O and Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26, 3279-3290   DOI
13 Lee CH, Yun HJ, Kang HS and Kim HD (1999) ERK/MAPK pathway is required for changes of cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells. IUBMB Life 48, 585-591   DOI
14 Baldin V, Lukas J, Marcote MJ, Pagano M and Draetta G (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7, 812-821   DOI
15 Altenberg B and Greulich KO (2004) Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84, 1014-1020   DOI
16 Yang W, Zheng Y, Xia Y et al (2012) ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol 14, 1295-1304   DOI
17 Shackelford DB and Shaw RJ (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9, 563-575   DOI
18 Juliano RL and Haskill S (1993) Signal transduction from the extracellular matrix. J Cell Biol 120, 577-585   DOI
19 Clark EA and Brugge JS (1995) Integrins and signal transduction pathways: the road taken. Science 268, 233-239   DOI
20 Guan JL (1997) Role of focal adhesion kinase in integrin signaling. Int J Biochem Cell Biol 29, 1085-1096   DOI
21 Mitra SK and Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18, 516-523   DOI
22 Nagano O and Saya H (2004) Mechanism and biological significance of CD44 cleavage. Cancer Sci 95, 930-935   DOI
23 Xu H, Tian Y, Yuan X et al (2016) Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis. Onco Targets Ther 9, 431-444
24 Grover-McKay M, Walsh SA, Seftor EA, Thomas PA and Hendrix MJ (1998) Role for glucose transporter 1 protein in human breast cancer. Pathol Oncol Res 4, 115-120   DOI
25 Schlaepfer DD, Mitra SK and Ilic D (2004) Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 1692, 77-102   DOI
26 Klingbeil P, Natrajan R, Everitt G et al (2010) CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification. Breast Cancer Res Treat 120, 95-109   DOI
27 Jordan M and Wurm F (2004) Transfection of adherent and suspended cells by calcium phosphate. Methods 33, 136-143   DOI